DarioHealth Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on January 28, 2021, covering events occurring on January 26, 2021. DarioHealth Corp. (DRIO) announced two material transactions: the acquisition of Upright Technologies Ltd. and a private placement equity offering.
Key Financial Metrics and Transactions
- Acquisition Consideration: The aggregate consideration for the Upright Technologies acquisition is capped at $31,000,000. This includes up to 1,800,000 shares of DarioHealth common stock (valued at $15.72 per share), assumed stock options, and the conversion of a $1,500,000 bridge loan. Estimated expenses of $3,700,000 will be deducted from the aggregate consideration.
- Private Placement Proceeds: The Company agreed to sell 3,278,688 shares of common stock to institutional accredited investors at $21.35 per share, generating gross proceeds of $70,000,000. Closing is scheduled for February 1, 2021.
- Transaction Fees: Placement agents (Cowen, Stifel, and Stern Aegis Ventures) will receive an aggregate cash fee of $4,900,000 (7% of gross proceeds).
- Liquidity Position: As of December 31, 2020, the Company estimated cash and cash equivalents at approximately $28.6 million.
- Recent Revenue: Estimated revenue for the quarter ended December 31, 2020, was approximately $2.12 million.
Material Changes and Agreements
The primary material change is the entry into definitive agreements to acquire Upright Technologies, a developer of posture correction technology, and to raise significant capital. The acquisition will result in Upright becoming a wholly-owned subsidiary. The transaction involves a complex vesting schedule for the selling shareholders, with shares restricted from transfer for periods ranging from 180 to 450 days. Additionally, 30% of the founder's consideration is subject to a specific holdback retention mechanism tied to 12 and 18-month milestones.
Outlook, Risks, and Contingencies
- Closing Conditions: The Upright acquisition is subject to customary conditions, including the accuracy of representations, regulatory approvals, and obtaining an interim opinion from Israeli tax authorities.
- Termination Rights: Either party may terminate the Upright agreement if closing does not occur within 90 days of execution (unless extended) or if a governmental authority objects.
- Indemnification: Losses arising from breaches of representations or warranties will be satisfied by forfeiting escrowed shares of common stock.
- Management Changes: Upright founder Oded Cohen will serve as General Manager MSK, receiving a monthly salary of NIS 63,000, an annual bonus of up to 4 salaries, and up to 220,980 restricted stock units subject to performance metrics.
Investor Verification Checklist
- Verify the final closing date of the $70 million private placement and the actual number of shares issued.
- Confirm the final valuation of the Upright acquisition and the exact number of Consideration Shares issued after working capital adjustments.
- Monitor the status of the Israeli tax authority interim opinion required for the Upright closing.
- Review the registration statement for the resale of shares by selling shareholders and placement agents, expected within 60 to 90 days post-closing.
- Assess the impact of the $4.9 million placement fee and $3.7 million expense deduction on net cash proceeds.